Theodora Cohen

461 total citations
16 papers, 320 citations indexed

About

Theodora Cohen is a scholar working on Infectious Diseases, Economics and Econometrics and Molecular Biology. According to data from OpenAlex, Theodora Cohen has authored 16 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Economics and Econometrics and 3 papers in Molecular Biology. Recurrent topics in Theodora Cohen's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Anesthesia and Neurotoxicity Research (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Theodora Cohen is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Anesthesia and Neurotoxicity Research (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Theodora Cohen collaborates with scholars based in United States, United Kingdom and Netherlands. Theodora Cohen's co-authors include Sandeep Dutta, Michael D. Karol, Thomas J. Ebert, Ritu Lal, Timothy Mant, Harry P. Selker, Dana M. Cairns, F. Chast, Denis Brossard and Paul A. Krieger and has published in prestigious journals such as Gastroenterology, Cancer and Journal of Allergy and Clinical Immunology.

In The Last Decade

Theodora Cohen

13 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Theodora Cohen United States 8 165 80 69 59 47 16 320
Adam Mikstacki Poland 10 98 0.6× 88 1.1× 27 0.4× 58 1.0× 9 0.2× 20 311
Sami A. Abu‐Halaweh Jordan 11 249 1.5× 65 0.8× 39 0.6× 283 4.8× 9 0.2× 29 512
C. Ricard France 9 94 0.6× 21 0.3× 20 0.3× 119 2.0× 9 0.2× 20 288
Barbara Tamowicz Poland 9 51 0.3× 24 0.3× 17 0.2× 24 0.4× 5 0.1× 11 183
Luc Desfrère France 13 54 0.3× 11 0.1× 17 0.2× 97 1.6× 4 0.1× 28 509
L Signore Italy 8 19 0.1× 18 0.2× 28 0.4× 38 0.6× 8 0.2× 17 310
Janet L. Fox United States 13 83 0.5× 12 0.1× 12 0.2× 82 1.4× 3 0.1× 45 436
Fabio De Iaco Italy 8 46 0.3× 8 0.1× 9 0.1× 62 1.1× 6 0.1× 30 242
James J. Thomas United States 10 51 0.3× 7 0.1× 8 0.1× 64 1.1× 7 0.1× 25 306
Hartmuth Nowak Germany 11 21 0.1× 11 0.1× 62 0.9× 40 0.7× 2 0.0× 37 299

Countries citing papers authored by Theodora Cohen

Since Specialization
Citations

This map shows the geographic impact of Theodora Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodora Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodora Cohen more than expected).

Fields of papers citing papers by Theodora Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodora Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodora Cohen. The network helps show where Theodora Cohen may publish in the future.

Co-authorship network of co-authors of Theodora Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Theodora Cohen. A scholar is included among the top collaborators of Theodora Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theodora Cohen. Theodora Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lumry, William R., et al.. (2025). Safety and pharmacokinetics of long-acting plasma kallikrein inhibitor navenibart (STAR-0215) in healthy adults. Annals of Allergy Asthma & Immunology. 135(1). 103–111.e2. 2 indexed citations
2.
Jacobs, Joshua, Adil Adatia, Timothy Craig, et al.. (2025). Treatment with Navenibart (STAR-0215) Reduces Attack Severity and Use of Rescue Medication in Patients with Hereditary Angioedema (HAE): Interim Results from the ALPHA-STAR Trial. Journal of Allergy and Clinical Immunology. 155(2). AB196–AB196.
3.
Craig, Timothy, Raffi Tachdjian, Marc A. Riedl, et al.. (2024). STAR-0215 INDUCES RAPID IMPROVEMENTS OF QUALITY OF LIFE IN HAE PATIENTS IN THE ALPHA-STAR TRIAL. Annals of Allergy Asthma & Immunology. 133(6). S26–S26. 1 indexed citations
4.
Lane, Karen, Ryan Majkowski, Sarah J. Nelson, et al.. (2024). Selecting trial centers using a standardized, automated site assessment survey instrument (SASI). Contemporary Clinical Trials. 143. 107583–107583.
5.
Cairns, Dana M., Dorothy Dulko, Jeffrey K. Griffiths, et al.. (2022). Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19. JAMA Network Open. 5(2). e2144942–e2144942. 40 indexed citations
6.
7.
Allegretti, Jessica R., Monika Fischer, Theodora Cohen, et al.. (2022). 583: CP101, AN INVESTIGATIONAL ORALLY ADMINISTERED MICROBIOME THERAPEUTIC, WAS EFFECTIVE FOR PREVENTION OF RECURRENT C. DIFFICILE INFECTION: RESULTS FROM OPEN-LABEL PRISM-EXT TRIAL. Gastroenterology. 162(7). S–143. 3 indexed citations
8.
Selker, Harry P., Theodora Cohen, Ralph B. D’Agostino, et al.. (2021). A Useful and Sustainable Role for N‐of‐1 Trials in the Healthcare Ecosystem. Clinical Pharmacology & Therapeutics. 112(2). 224–232. 23 indexed citations
9.
Selker, Harry P., Hans‐Georg Eichler, Norman Stockbridge, et al.. (2019). Efficacy and Effectiveness Too Trials: Clinical Trial Designs to Generate Evidence on Efficacy and on Effectiveness in Wide Practice. Clinical Pharmacology & Therapeutics. 105(4). 857–866. 23 indexed citations
10.
Selker, Harry P., Robin Ruthazer, James E. Udelson, et al.. (2018). An example of medical device-based projection of clinical trial enrollment: Use of electrocardiographic data to identify candidates for a trial in acute coronary syndromes. Journal of Clinical and Translational Science. 2(6). 377–383. 1 indexed citations
11.
Dutta, Sandeep, et al.. (2001). Effect of dexmedetomidine on propofol requirements in healthy subjects. Journal of Pharmaceutical Sciences. 90(2). 172–181. 78 indexed citations
12.
Dutta, Sandeep, Ritu Lal, Michael D. Karol, Theodora Cohen, & Thomas J. Ebert. (2000). Influence of Cardiac Output on Dexmedetomidine Pharmacokinetics. Journal of Pharmaceutical Sciences. 89(4). 519–527. 103 indexed citations
13.
Krieger, Paul A., Theodora Cohen, & Sonya Naryshkin. (1998). A practical guide to papanicolaou smear rescreens. Cancer. 84(3). 130–137. 11 indexed citations
14.
Cohen, Theodora, et al.. (1996). Amphotericin B eye drops as a lipidic emulsion. International Journal of Pharmaceutics. 137(2). 249–254. 25 indexed citations
15.
Cohen, Theodora & Bruce D. Spencer. (1991). Shrinkage Weights for Unequal Probability Samples. 1 indexed citations
16.
Cohen, Theodora, et al.. (1960). Liver function studies in the aged.. PubMed. 15. 824–36. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam Mikstacki Breakdown of academic impact, for papers by Sami A. Abu‐Halaweh Breakdown of academic impact, for papers by C. Ricard Breakdown of academic impact, for papers by Barbara Tamowicz Breakdown of academic impact, for papers by Luc Desfrère Breakdown of academic impact, for papers by L Signore Breakdown of academic impact, for papers by Janet L. Fox Breakdown of academic impact, for papers by Fabio De Iaco Breakdown of academic impact, for papers by James J. Thomas Breakdown of academic impact, for papers by Hartmuth Nowak
Rankless by CCL
2026